ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,064.00
      -0.08%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.67%
      Bitcoin
      66,852.36
      2.47%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vaxart Inc (VXRT)

      7. Vaxart Inc (VXRT) News

      VXRT

      Vaxart (VXRT)

      Vaxart Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VXRT
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      05/13/20244:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
      05/13/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      05/13/20244:01PMGlobeNewswire Inc.Vaxart Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
      05/13/20247:10AMIH Market NewsU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed ReactionsNASDAQ:VXRTVaxart Inc
      05/07/20248:00AMGlobeNewswire Inc.Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13NASDAQ:VXRTVaxart Inc
      04/30/20248:00AMGlobeNewswire Inc.Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
      03/27/20248:00AMGlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024 on April 3NASDAQ:VXRTVaxart Inc
      03/20/20248:00AMGlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
      03/14/20244:01PMGlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
      03/14/20247:41AMIH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil Prices ClimbNASDAQ:VXRTVaxart Inc
      03/07/20248:00AMGlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14NASDAQ:VXRTVaxart Inc
      03/06/20249:23AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      03/06/20248:00AMGlobeNewswire Inc.Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorNASDAQ:VXRTVaxart Inc
      02/29/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      02/15/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      02/13/20245:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VXRTVaxart Inc
      02/05/20248:00AMGlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeNASDAQ:VXRTVaxart Inc
      02/02/20244:49PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VXRTVaxart Inc
      01/19/20245:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      01/19/20244:30PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VXRTVaxart Inc
      01/19/20248:30AMGlobeNewswire Inc.Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
      01/16/20245:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      01/16/20249:25AMGlobeNewswire Inc.Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementNASDAQ:VXRTVaxart Inc
      01/16/20249:22AMGlobeNewswire Inc.Vaxart, Inc. Announces Management ChangeNASDAQ:VXRTVaxart Inc
      01/16/20249:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      12/21/20238:00AMGlobeNewswire Inc.Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
      11/02/20234:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
      11/02/20234:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
      11/02/20234:01PMGlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
       Showing the most relevant articles for your search:NASDAQ:VXRT